• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Intensive Care . Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the f

tetano

Editor, Senior Moderator
Ann Intensive Care


. 2022 Jan 13;12(1):5.
doi: 10.1186/s13613-021-00978-3.
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands


Dave A Dongelmans[SUP] 1 2 [/SUP], Fabian Termorshuizen[SUP] 3 4 [/SUP], Sylvia Brinkman[SUP] 1 5 [/SUP], Ferishta Bakhshi-Raiez[SUP] 1 5 [/SUP], M Sesmu Arbous[SUP] 1 6 [/SUP], Dylan W de Lange[SUP] 1 7 [/SUP], Bas C T van Bussel[SUP] 8 9 [/SUP], Nicolette F de Keizer[SUP] 1 5 [/SUP], Dutch COVID-19 Research Consortium



Collaborators, Affiliations

Abstract

Background: To assess trends in the quality of care for COVID-19 patients at the ICU over the course of time in the Netherlands.
Methods: Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU in the Netherlands were used. Patient characteristics and indicators of quality of care during the first two upsurges (N = 4215: October 5, 2020-January 31, 2021) and the final upsurge of the second wave, called the 'third wave' (N = 4602: February 1, 2021-June 30, 2021) were compared with those during the first wave (N = 2733, February-May 24, 2020).
Results: During the second and third wave, there were less patients treated with mechanical ventilation (58.1 and 58.2%) and vasoactive drugs (48.0 and 44.7%) compared to the first wave (79.1% and 67.2%, respectively). The occupancy rates as fraction of occupancy in 2019 (1.68 and 1.55 vs. 1.83), the numbers of ICU relocations (23.8 and 27.6 vs. 32.3%) and the mean length of stay at the ICU (HRs of ICU discharge = 1.26 and 1.42) were lower during the second and third wave. No difference in adjusted hospital mortality between the second wave and the first wave was found, whereas the mortality during the third wave was considerably lower (OR = 0.80, 95% CI [0.71-0.90]).
Conclusions: These data show favorable shifts in the treatment of COVID-19 patients at the ICU over time. The adjusted mortality decreased in the third wave. The high ICU occupancy rate early in the pandemic does probably not explain the high mortality associated with COVID-19.

Keywords: COVID-19; Coronavirus; Critical Care; Intensive Care; Mortality; Outcome.
 
Back
Top Bottom